MentionFox
Home › funding signals › Reprise Biomedical, Inc.
Company · SEC filings

Reprise Biomedical, Inc. funding history

Reprise Biomedical, Inc. has 7 Form D filings on record, from 2023-01-03 to 2026-07-01. Together its new offerings report $1.45M sold.

Funding historyFounders and team

What do you want to do with Reprise Biomedical, Inc.?

Based
Plymouth, MINNESOTA
Industry group
Biotechnology
Filings
7
Raised (new offerings)
$1.45M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-07-01Amendment
first sale 2026-05-14
$9.25M$10MSEC filing
2026-05-21New offering
first sale 2026-05-14
$1.45M$8MSEC filing
2025-07-11Filing——SEC filing
2023-12-13Amendment——SEC filing
2023-11-02Filing——SEC filing
2023-01-25Amendment——SEC filing
2023-01-03Filing——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Reprise Biomedical, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/reprise-biomedical-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Reprise Biomedical, Inc. funding history: 7 SEC filings, $1.45M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/reprise-biomedical-inc